Michael Feld (BDX) lists planned 10b5-1 sales via Morgan Stanley (BDX)
Rhea-AI Filing Summary
Becton, Dickinson and Company (BDX) proposed resale notice filed for Common Stock sales by Michael Feld. The filing lists 10b5-1 planned sales of 75 shares on 05/26/2026 at $11,051.25 and 74 shares on 04/27/2026 at $11,243.56. The excerpt also shows 75 Restricted Stock Units with an 08/20/2025 grant date. The filing records the broker as Morgan Stanley Smith Barney LLC.
Positive
- None.
Negative
- None.
Insights
Routine 10b5-1 dispositions by an insider; transactional details are small-scale.
The excerpt shows two proposed sales under 10b5-1 arrangements: 75 shares on 05/26/2026 at $11,051.25 and 74 shares on 04/27/2026 at $11,243.56. These entries are typical notice filings that report planned dispositions rather than open-market discretionary sales.
Timing and cash‑flow recipients are the selling holder and broker as listed; subsequent Form 4 or trade reports would confirm execution. Future filings may provide confirmation of completion or any tax/withholding mechanics.
Key Figures
Key Terms
10b5-1 regulatory
Form 144 regulatory
Restricted Stock Units financial
FAQ
What does the BDX Form 144 excerpt show about Michael Feld's sales?
Were any Restricted Stock Units (RSUs) mentioned in the BDX filing?
Which broker is listed for the proposed sales in the BDX excerpt?
Do these Form 144 entries confirm the sales were executed?
AI-generated analysis. How Rhea-AI works. Not financial advice.